↓ Skip to main content

Double trouble for prostate cancer: synergistic action of AR blockade and PARPi in non-HRR mutated patients

Overview of attention for article published in Frontiers in oncology, September 2023
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (81st percentile)
  • High Attention Score compared to outputs of the same age and source (95th percentile)

Mentioned by

twitter
13 X users

Citations

dimensions_citation
3 Dimensions

Readers on

mendeley
9 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Double trouble for prostate cancer: synergistic action of AR blockade and PARPi in non-HRR mutated patients
Published in
Frontiers in oncology, September 2023
DOI 10.3389/fonc.2023.1265812
Pubmed ID
Authors

Alexander Giesen, Loïc Baekelandt, Wout Devlies, Gaëtan Devos, Herlinde Dumez, Wouter Everaerts, Frank Claessens, Steven Joniau

X Demographics

X Demographics

The data shown below were collected from the profiles of 13 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 9 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 9 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 2 22%
Researcher 2 22%
Professor > Associate Professor 1 11%
Unknown 4 44%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 1 11%
Biochemistry, Genetics and Molecular Biology 1 11%
Medicine and Dentistry 1 11%
Unknown 6 67%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 January 2024.
All research outputs
#4,374,095
of 26,238,332 outputs
Outputs from Frontiers in oncology
#1,477
of 22,943 outputs
Outputs of similar age
#67,482
of 362,820 outputs
Outputs of similar age from Frontiers in oncology
#43
of 997 outputs
Altmetric has tracked 26,238,332 research outputs across all sources so far. Compared to these this one has done well and is in the 83rd percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 22,943 research outputs from this source. They receive a mean Attention Score of 3.1. This one has done particularly well, scoring higher than 93% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 362,820 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 81% of its contemporaries.
We're also able to compare this research output to 997 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 95% of its contemporaries.